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Abstract
200 million people worldwide are living with a thyroid disorder related to a hormonal imbalance.
Symptoms of this imbalance include deviations from normal heart rates and metabolic rates. A chemical
messenger known as T3 has been shown to raise cardiac and metabolic rates, but this takes place on a
timescale of hours. However, recent discoveries have revealed that a different thyroid hormone known
as T1AM is capable of affecting some of these same physiological conditions in a matter of minutes.
T1AM is a potent, selective agonist for the Trace Amine Associated Receptor (TAAR). Several studies
have probed the structural basis of T1AM activation, but these studies have not yet provided a complete
picture. Based on these findings, we have developed a new molecular scaffold that incorporates key
structural features in a conformationally-restricted arrangement. For example, the incorporation of a
six carbon ring in our target compounds will confine the location of the amine and even create multiple
stereocenters. Furthermore, several chiral locations on this scaffold will have structural variability. To
date, our research has focused on optimizing the reactions that produce 3-nitro-2H-chromenes, the
chemical precursors to these target compounds. The successful production of a panel of these
chromenes has set the stage for subsequent reactions that will allow us to generate many T1AM
analogues. By understanding the regulation of TAAR we may gain a greater understanding of its role in
biology and human physiology.
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Background
The thyroid gland in vertebrates regulates normal physiology by
secreting hormones, the predominant one being Thyroxine (T4,
figure 1). In target tissues T4 is modified by the removal of an
iodine atom to generate 3,5,3’-triiodothyronine (T3, figure 2), a
high affinity ligand for nuclear receptors TRα and TRβ (Scanlan

Figure 1. Thyroxine (T4)

2004). The effects of T3 include increased heart rate, increased
metabolic rate, and raised core body temperature. Because the
effects of T3 are communicated through a transcription
pathway, they are manifested over a period of hours or days

Figure 2. 3,5,3’-Triidothyronine (T3)

(Scanlan 2004). Overproduction of T3 is known as
hyperthyroidism and is a common hormonal imbalance marked by increasing cardiac rate, metabolic
rate, and core body temperature.
T3 can be modified still further by decarboxylation and the removal of two more iodine atoms to
form 3-iodothyronamine (T1AM, figure 3), another hormone with an important role in vertebrate
homeostasis. When T1AM was administered to mice, they
showed immediate inactivity, ptosis (drooping eyelids) and
reduced body temperature. Furthermore, the injection of
T1AM into isolated rat hearts induced bradycardia in

Figure 3. 3-Iodothyronamine (T1AM)

approximately ten minutes (Scanlan 2004). These effects constitute the opposite of T3 but occur in a
matter of minutes, an indication that T1AM communicates through a direct pathway, unlike that of T3.
Thus it came as no surprise when T1AM was shown to not have an affinity for the receptors TRα or TRβ.
Instead, administering T1AM to HEK293 cells expressing the rat Trace Amine Associated Receptor
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(rTAAR) resulted in cAMP accumulation (Scanlan 2004). Further tests confirmed that T1AM does indeed
bind preferentially to TAAR from species of rats and mice (mTAAR), while T3 and T4 do not (Scanlan
2004). Based on these findings, it is believed that TAAR is responsible for communicating the effects of
T1AM such as ptosis and bradycardia in mice.
The Trace Amine Associated Receptor is a G protein-coupled receptor (GPCR) similar to β2
adrenergic (β2AR), dopamine, and serotonin receptors. Since these receptors all belong to the same
subfamily of class A rhodopsin-like GPCRs, the
structure of β2AR can serve as an model for
understanding the structure of TAAR (Tan 2008). A
GPCR like β2AR is composed of seven transmembrane
(TM) proteins and contains a binding site located
among TM 3, 5, 6, and 7 (figure 4). Projecting from
TM1 there is an amino terminus, and TM7 ends in a

Figure 4. Cross Section of GPCR

carboxy terminus (Tan 2008).
In the inactive state of β2AR, there is ionic lock
between TM6 and TM3 composed of a glutamic acid residue
in TM6 (E6.30) and aspartic acid and arginine residues
(D3.49 and R3.50) in TM3 (Tan 2008). When an agonist
enters the binding pocket, it induces a conformational
change that breaks this ionic lock, allowing TM6 to pivot
away from TM3 (figure 5). As a result, the G protein
recognition sites on the intracellular surface of the receptor
are exposed, initiating a signaling cascade (Tan 2008). Since
Figure 5. Active Conformation of β2AR
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TAAR contains the same pertinent amino acid residues, the mechanism for agonist binding likely occurs
the same way. Interestingly, binding is not simply a one step process but rather a sequence of
increasing interactions between the agonist and intermediate conformational states of the receptor that
culminate when the fully active state is reached (Tan 2008). TAAR may prove to have similarly complex
ligand receptor interactions.
To better understand these interactions, the structure activity relationship (SAR) of rTAAR and
mTAAR was probed by various synthetic T1AM analogues. Since one of the distinguishing features of
T1AM relative to T3 is the number and location of iodine atoms, thyronamines were synthesized with
anywhere from zero to four iodine atoms at various locations on the aryl rings. It was found that any
change to the number or position of iodine atoms relative to T1AM reduced TAAR activation (Hart
2006). Still, a T1AM analogue without any iodine atoms (T0AM) did exhibit enough TAAR activation to
serve as template for further SAR investigations. In addition,
removal of the hydroxyl from T0AM (figure 6) was beneficial
for both rTAAR and mTAAR affinity relative to T0AM (Hart

Figure 6. New Elementary Scaffold

2006). This established a convenient, elementary scaffold for
variance in future analogues (figure 6).
Two different sites of modification relative to this scaffold were the bridges, one a biaryl ether
connecting the two rings and the other an ethyl group supporting the amine. Lengthening the biaryl
ether by adding methylene groups generally improved mTAAR activation but was detrimental to rTAAR
activation (Hart 2006). Interestingly, when a long
enough bridge had been reached (figure 7),
mTAAR and rTAAR activation stabilized,
Figure 7. Long Biaryl Bridge
suggesting that the compound was able to adopt
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whatever conformation best suited the receptor. Based on these results, the original biaryl ether bridge
appeared to be sufficient for future analogues. Modifications were also made to the ethyl bridge
supporting the amine by attaching an amide to the ring and adjusting the linkage length to the amine, as
in figure 8. Generally, these compounds were poor agonists for
both mTAAR and rTAAR (Tan 2007), although bridges of
sufficiently long length gradually improved activation potential,
again suggesting that enough flexibility was achieved to adopt

Figure 8. Poor TAAR Agonist

whatever conformation was needed to match the TAAR binding
site. Preserving the original bridge supporting the amine in T1AM was the most rational structure for
further agonists.
One final modification of obvious significance is the basic amine. Replacing the amine with a
hydroxyl group abolished rTAAR and mTAAR affinity, demonstrating that this functional group is
essential for TAAR activation (Hart 2006). Different alkylation
states of the amine were also explored. In general,
monomethylation (figure 9) was tolerated for both rTAAR and
mTAAR, but longer alkyl chains and dimethylation of any sort were

Figure 9. Monomethylation

detrimental (Hart 2006).
These findings provided a foundation for developing rTAAR superagonists, or compounds that
have an affinity for the receptor that exceeds T1AM. The rational basis for making further modifications
involved a proposed binding orientation and its surrounding amino acid residues in rTAAR. Appending a
phenyl group to the carbon in the β position to the amine provided a strategic location for attaching
polar functional groups to interact with asparagines (N7.35 and N7.39), methionine (M6.55) and
cysteine (C6.54) (Tan 2008). This new structural scaffold, shown in figure 10, exhibited unprecedented
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affinity for rTAAR. Interestingly, monomethylation of the amine
also improved activation for this compound (Tan 2008). This
method of design, introducing functional groups to accommodate
the residues surrounding a proposed binding orientation, was
very successful at generating superagonists.

Figure 10. rTAAR Superagonist

Another avenue of SAR research involves antagonists, compounds that inhibit receptor
activation. Antagonists are structurally similar to agonists since they still must have an affinity for the
receptor, but they differ in key ways in order to prevent activation
upon binding. Figure 11 shows a potent rTAAR antagonist that
contains two crucial structural modifications from the
superagonist scaffold. First of all, the R group has been apended
in a precise location where it can interfere with the motion of the

Figure 11. R = OHex, OPent

rotamer toggle switch. This steric obstruction encumbers the
conformational change that would normally accompany activation. As a result, compounds containing
especially bulky R groups, such as pentane or hexane ethers, were the most capable of sterically
impeding this motion and performed the best as antagonists. The second essential modification was
repositioning the phenyl ether, which was necessary to eliminate the symmetry of the molecule and
restrict the binding orientation of the compound. Antagonists based on this structure exhibited
inhibition of T1AM activation in competition assays, albiet in modest concentrations (Tan 2008).
Based on all these SAR studies, we have developed a novel molecular scaffold that incorporates
these components in a new arrangement (figure 12). Essential features including the basic amine and
biaryl linkage have been conserved, while nonessential moities such as the hydroxyl group and iodine
have not. However, the most significant structural revision is the cyclization of the ring connected to the
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α carbon to the amine. This increases the rigidity of the
compound and confines the location of the amine, which
can be controlled even further because it is attached to a
chiral carbon. Two crucial points of variation also exist on

Figure 12. Novel Scaffold

this scaffold at the R1 and R2 positions. Based on past
superagonist structures, appending a phenyl ring at the R1 position provides a location for polar
functional groups that can have interactions with the receptor. Furthermore, the variability at the R2
position could be exploited to generated antagonists by appending bulky groups such as hexane ethers.
The potential for stereoisomers involving three chiral centers, at the amine, R1, and R2 positions, allows
us to exert a tremendous amount of control over the exact spatial positioning of all these groups.
Results and Discussion
Our laboratory work has been focused on optimizing the synthesis of this scaffold (scheme 1).

Scheme 1. Retrosynthetic Plan

Lehmann 9
The first step in this strategy is the production of 3-nitro-2H-chromenes, compounds that contain nitro
groups that serve as precursors to amines. These nitrochromenes also have hydroxyl groups that will
later facilitate the attachment of phenyl ethers. To date, two different reactions have been employed to
generate a panel of nitrochromenes varying at the R2 position and at the location of the –OH group that
will later be replaced by a phenyl ether.
The first successful procedure for synthesizing these nitrochromenes utilizes the same
substrates as shown in scheme 1. Salicylaldehyde (1 eq.) and nitroethanol (1.6 eq.) are to be mixed with
di-n-butylammonium chloride (DBAC, 0.5 eq.) in the solvent isopentyl acetate (Dauzonne 1984). Instead
of using DBAC, we employed dibutylamine and then generated HCl in situ by mixing acetyl chloride and
isopentanol. Another important factor was the utilization of a Dean Stark apparatus, which was
essential for collecting the water produced by the reaction. By Le Chatelier’s Principle, this removal of
product helped push the reaction toward completion. We were unable to duplicate the yield reported
in this paper, generating only a 16% yield instead of the reported 50%. Next, this reaction was applied
to different substrates, including 2,4-dihydroxybenzaldehyde and 2,5-dihydroxybenzaldehyde, with the
yield for the latter reaching 24.4%.
The second successful method of nitrochromene formation was based on the Morita-BaylisHillman reaction (scheme 2). According to the literature, the best mixture for this reaction was 1

Scheme 2. Morita-Baylis-Hillman Based Nitrochromene formation
equivalent of the nitroalkene, 1 equivalent of formaldehyde, 1 equivalent of imidazole, and 10 mol % of
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anthranilic acid in THF at room temperature (Rastogi 2004). We changed this procedure significantly by
employing salicylaldehyde instead of formaldehyde and refluxing the reaction in ethyl acetate and later
propyl acetate (scheme 2). These temperatures proved conducive to chromene formation and yields of
approximately 20% were reached, although the product was difficult to purify by column
chromatography because the reactants had the same Rf as the product. We also discovered that using a
Dean Stark apparatus to remove water improved yields for this reaction as well.
Another chromene formation tactic that we attempted was solvent free and facilitated by a
regular household microwave (Scheme 3). We were unable to generate any nitrochromenes by
following the synthesis outlined in the article (Koussini 2008) or by making modifications including

X

Scheme 3. Microwave Assisted Chromene Formation
raising the amount of TBAB to a stoichiometric quantity and adjusting the microwaving time intervals.
However, based on how the Dean Stark apparatus was necessary for removing water from the one-pot
synthesis reaction and Morita-Baylis-Hillman reaction, adding molecular sieves to remove water from
this reaction might push it to completion in a similar way. We intend to try this in the future while we
continue to optimize the other chromene formation reactions that have succeeded.
The last step in scheme 1 is reduction of the amine, but testing this chemistry on a model
system provided a cheaper more precedented way to optimize it (scheme 4). The literature used 3,4-

Scheme 4. Model System of Hydrogenation

Lehmann 11
methylenedioxy-β-nitrostyrene (Kohno 1990), a trans-nitrostyrene with a different pattern of aromatic
substitution than the substrate shown in scheme 4. In addition, the specific catalyst called for, 5% Pd/C
K-type was not readily available, so 10% Pd/C was used instead. After the reaction was stopped, boc
anhydride was added to protect the amine from decomposition. Even with all of these modifications,
promising peaks were still visible on NMR, although further optimization and purification steps are
required before any yields can be reported.
The success of the first stage of this synthesis includes the utilization of two different chromene
formation reactions and the production of a panel of nitrochromenes. Exploring the reduction of these
nitrochromenes with a model system was the first step in converting these precursors into TAAR
regulators. However, much more still needs to be done. Based on the retrosynthetic plan (scheme 1),
several more reactions are required to append other moieties and complete the target scaffold. These
challenges will provide plenty of inquiries for further laboratory investigations over the next year.

Conclusion and Future Directions
A very important step in the completion of this scaffold is replacement of the hydroxyl group
with a phenyl ether, which is accomplished by a copper coupling reaction (scheme 5). This chemistry

Scheme 5. Copper Coupling
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has already been utilized in the lab, and will be extended in the nitrochromene case. Still, the creation
of novel TAAR regulators requires this structural alteration.
Conjugate addition to the nitrochromene provides variation at the R1 position, a modification
that could be used to generate superagonists and lead antagonists. One method of conjugate addition

Scheme 6. Organocatalytic Malonate Addition (Michael Addition)
is organocatalytic malonate addition (scheme 6). While the range of groups that can be added to
nitroalkenes is limited, the literature on this reaction reports achievement of enantioselectivity (Chen
2011). The second method of conjugate addition that could be employed is organocopper addition, a
multistep process inolving organometallics (scheme 7). A wide variety of substrates are compatible with
this reaction, providing a great potential for variation at a position that has already been utilized in the
development of superagonists. Enantioselectivity of this step will also be explored.

Scheme 7. Organocopper addition
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TAAR performs a crucial role in normal vertebrate physiology that is still being resolved. Upon
activation by the selective agonist T1AM, TAAR initiates rapid and acute effects on cardiac rate,
metabolic rate, and body temperature. SAR studies of this receptor with T1AM analogues have shown
what structural features are essential for TAAR affinity, and rational molecular design based on binding
orientation has led to highly effective agonists and antagonists. We hope to produce novel TAAR
regulators by incorporating these moieties into a rigid, conformationally-restricted scaffold. Even
though our synthesis has not been completed yet, the successful production of a panel of substituted 3nitro-2H-chromenes has provided many precursors for the creation diverse panel of target compounds.
As we continue optimizing the synthesis of TAAR regulators, we expect to learn more about the nature
of this important receptor.
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